research

AlloSource Announces Two Presentations on ProChondrix at the International Cartilage Repair Society World Congress

Centennial, Colo. — April 10, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that clinical and scientific data on its ProChondrix® osteochondral allograft will be presented at the International Cartilage Repair Society’s 14th World Congress on Wednesday, April 11 from 13:00-14:00 in the Almaty 3 Room. Dr. Vishal Mehta will present his 24-month clinical experience with ProChondrix in the knee. Dr. Mehta performed the first ProChondrix implantation in December of 2014 and will share his clinical experience with the product. “ProChondrix has been a valuable addition to my…

Preclinical Study Validates Science Behind AlloSource’s AlloStem Cellular Bone AlloGraft

Centennial, Colo. — July 6, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced that Dr. Nicole Ehrhart, Professor of Surgical Oncology at the Colorado State University (CSU) Flint Animal Cancer Center, presented preclinical data on adiposederived mesenchymal stem cells at the State of Spine Surgery 13th Annual Symposium and will present at the Korean American Spine Society meeting on July 9, 2016. Dr. Ehrhart’s preclinical study, entitled Adipose-Derived Mesenchymal Stromal Cells Seeded on Demineralized Bone Matrix Persist…